Hemoglobin A1c as a metabolic risk indicator for cardiovascular morbidity in schizophrenia

Autor:	Yasin Hasan Balcioglu, A. Genc, N. Durak, M. Emul, N. Karamustafalioglu, T. Kalelioglu
Rok vydání:	2016
Předmět:	Pharmacology medicine.medical_specialty business.industry Schizophrenia (object-oriented programming) Metabolic risk Psychiatry and Mental health Neurology Medicine Pharmacology (medical) Neurology (clinical) Hemoglobin business Psychiatry Intensive care medicine Biological Psychiatry
Zdroj:	European Neuropsychopharmacology. 26:S582-S583
ISSN:	0924-977X
DOI:	10.1016/s0924-977x(16)31646-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c0f225ce089a642d259f9c254250f4d0 https://doi.org/10.1016/s0924-977x(16)31646-7 Zobrazit plný text záznamu Full Text from ScienceDirect